Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stevanato Group S.p.A (STVN) Finished Goods (2020 - 2025)

Stevanato Group S.p.A (STVN) reported Finished Goods of $116.0 million for Q4 2025, up 12.89% year-over-year from $102.8 million in Q4 2024, and up 12.89% on a QoQ basis from $102.8 million in Q4 2024.

Stevanato Group S.p.A (STVN) has 6 years of Finished Goods data on file, last reported at $116.0 million in Q4 2025.

  • Quarterly Finished Goods rose 12.89% year-over-year to $116.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $116.0 million (up 12.89% YoY) and the FY2025 annual result came in at $116.0 million, up 12.89% from the prior year.
  • Finished Goods climbed to $116.0 million in Q4 2025 per STVN's latest filing, from $102.8 million in the prior quarter.
  • Across five years, Finished Goods topped out at $121.6 million in Q4 2023 and bottomed at $73.5 million in Q4 2021.
  • The 5-year median for Finished Goods is $102.8 million (2024), against an average of $101.8 million.
  • The widest annual swing landed in 2022, when Finished Goods grew 29.08%; it then dropped 15.49% in 2024.
  • Tracing STVN's Finished Goods over 5 years: stood at $73.5 million in 2021, then increased by 29.08% to $94.9 million in 2022, then advanced by 28.18% to $121.6 million in 2023, then retreated by 15.49% to $102.8 million in 2024, then gained by 12.89% to $116.0 million in 2025.
  • Per Business Quant, the three latest STVN Finished Goods figures stand at $116.0 million (Q4 2025), $102.8 million (Q4 2024), and $121.6 million (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn
10 Stevanato Group S.p.A 5.73 Bn 5.59 Bn 88.04 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 116.03 Mn
Dec 31, 2024 102.78 Mn
Dec 31, 2023 121.62 Mn
Dec 31, 2022 94.88 Mn
Dec 31, 2021 73.50 Mn
Dec 31, 2020 66.05 Mn